Navigation Links
FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
Date:2/4/2008

target="_new">http://www.nhlbi.nih.gov/health/dci/Diseases/Asthma/Asthma_WhatIs.html

(6) "Asthma," an eMedicine manuscript by Michael J. Morris, MD, Assistant

Chief, Clinical Investigation, Dept. of Medicine, Brooke Army Medical

Hospital, updated February 9, 2005, http://www.emedicine.com (accessed

Tuesday, March 8, 2005).

(7) "Epidemiology of Nocturnal Asthma," Margaret Turner Warwick, DM,

Ph.D., FRCP. The American Journal of Medicine, July 29, 1988.

(8) "Asthma & Children Fact Sheet." American Lung Association, December

2007.

http://www.lungusa.org/site/apps/nl/content3.asp?c=dvLUK9O0E&b=

2058817&content_id={05C5FA0A-A953-4BB6-BB74-F07C2ECCABA9}¬oc=1

(Due to length of URL, please copy and paste into browser.)

(9) "Asthma's Impact on Children and Adolescents." Centers for Disease

Control and Prevention.

http://www.cdc.gov/asthma/children.htm


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Negative Pressure Wound Devices Draw FDA Notice, Advice 2DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 1BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 2BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 3BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 4BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 5BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 6BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 7BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 8BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 9BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 10BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 11BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 12BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 13BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 14BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 15House Judiciary Committee Hearing Calls Attention to Long Term Effects of Head Injury Among NFL Players 60291 1House Judiciary Committee Hearing Calls Attention to Long Term Effects of Head Injury Among NFL Players 60291 2Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation 5806 1Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation 5806 2